One minute you’re trying to lower your blood pressure, the next you’re battling cancer — and that’s only if you didn’t drop dead of a heart attack first.
Your premature demise wasn’t caused by your “high” blood pressure… it was caused by the drugs used to treat it, and two new studies paint the ugliest picture yet of the risks you face when you take those meds.
A study in The Lancet Oncology finds that patients who take any one of an entire class of hypertension meds, angiotensin-receptor blockers, are more likely to get cancer. The analysis of more than 60,000 patients who took part in five trials found a 10 percent increase in cancer versus those taking a placebo.
The researchers say the overall risk is small — but I’ve heard the same said about Russian roulette.
The bad news doesn’t end there, because one of those angiotensin-receptor blockers has been linked to an increased risk of heart death — not exactly a positive development for a med that’s supposed to prevent it!
Researchers were looking to see if Benicar could lower kidney risk in diabetics when they noticed that more people on the med were dying of heart-related problems than in the placebo groups, according to the FDA.
Once again, they claim the risk is small.
Small, maybe — but when does it end? A little cancer here, a few heart attacks there, and pretty soon you’re talking about a real death toll. Throw in the other risks from blood pressure meds — like impotence and diabetes — and you’ve got a disease party… and everyone has an invitation.
So forget these drugs — they’ll send your blood pressure plummeting to dangerously low levels anyway, because the frequently revised targets used by mainstream docs were practically written by Big Pharma itself — and they weren’t written with you in mind.
Blood pressure meds did $20.4 billion in sales last year, up from $13 billion in 2000.
That’s the real target.